Page last updated: 2024-08-26

nicotine and acamprosate

nicotine has been researched along with acamprosate in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aistrup, GL; Engel, JA; Ericson, M; Hedlund, L; Kalouti, U; Marszalec, W; Narahashi, T; Nordberg, A; Olausson, P; Schmidt, LG; Smolka And, M; Söderpalm, B; Zhang, X1
Beilby, JJ; Doran, CM; Duszynski, KM; Mattick, RP1
Diehl, A; Mann, K1
Spangler, JG1
Bholat, Y; Farrokhi, C; Lacayo, LM; Manalo, CM; Pechnick, RN; Reyes, KC; Spivak, I; Vit, JP1
Goutier, W; Kloeze, M; McCreary, AC1

Reviews

2 review(s) available for nicotine and acamprosate

ArticleYear
Mechanisms of alcohol-nicotine interactions: alcoholics versus smokers.
    Alcoholism, clinical and experimental research, 2001, Volume: 25, Issue:5 Suppl IS

    Topics: Acamprosate; Acetylcholine; Alcohol Deterrents; Alcoholism; Animals; Central Nervous System Depressants; Drug Interactions; Ethanol; Gene Expression; Humans; Male; Nicotine; Nicotinic Agonists; Rats; Receptors, Nicotinic; Reinforcement, Psychology; Secondary Prevention; Smoking; Taurine; Vasodilator Agents; Ventral Tegmental Area

2001
[Pharmacological relapse prevention in alcohol and tobacco dependence].
    Der Internist, 2007, Volume: 48, Issue:1

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Clinical Trials as Topic; Combined Modality Therapy; Disulfiram; Humans; Naltrexone; Nicotine; Psychotherapy; Secondary Prevention; Smoking Cessation; Substance Withdrawal Syndrome; Taurine; Tobacco Use Disorder

2007

Other Studies

4 other study(ies) available for nicotine and acamprosate

ArticleYear
Use of pharmacotherapies for the management of addictive behaviours in Australian clinical practice.
    Addictive behaviors, 2006, Volume: 31, Issue:11

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Australia; Bupropion; Dopamine Uptake Inhibitors; Female; Health Care Surveys; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Substance-Related Disorders; Taurine; Tobacco Use Disorder

2006
NMDA receptor blockade: a novel avenue for tobacco intervention?
    Medical hypotheses, 2008, Volume: 70, Issue:5

    Topics: Acamprosate; Central Nervous System Stimulants; Humans; Memantine; Models, Biological; Models, Theoretical; Neurons; Nicotiana; Nicotine; Prefrontal Cortex; Receptors, N-Methyl-D-Aspartate; Smoking Cessation; Taurine

2008
Acamprosate attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.
    Behavioural pharmacology, 2011, Volume: 22, Issue:3

    Topics: Acamprosate; Animals; Cues; Drug-Seeking Behavior; Male; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Self Administration; Taurine

2011
Nicotine-induced locomotor sensitization: pharmacological analyses with candidate smoking cessation aids.
    Addiction biology, 2016, Volume: 21, Issue:2

    Topics: Acamprosate; Analysis of Variance; Animals; Antidiuretic Hormone Receptor Antagonists; Bupropion; Dose-Response Relationship, Drug; Fructose; Indoles; Male; Motor Activity; Naltrexone; Nicotine; Nicotinic Agonists; Pyrrolidines; Rats, Wistar; Taurine; Tobacco Use Cessation Devices; Topiramate

2016